Načítá se...
L1CAM as a prognostic marker in stage I endometrial cancer: a validation study
BACKGROUND: L1 cell adhesion molecule (L1CAM) overexpression has been reported to be strongly associated with poor prognosis in early stage endometrial cancer (EC). We aimed at the validation of L1CAM as a marker of poor prognosis in an independent study population. METHODS: Patients with endometrio...
Uloženo v:
Vydáno v: | BMC Cancer |
---|---|
Hlavní autoři: | , , , , , , , |
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
BioMed Central
2016
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4973089/ https://ncbi.nlm.nih.gov/pubmed/27488577 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2631-4 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|